PATENT CLAIM ANALYSIS

Application Number: 15878297
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "275000"]

Abstract:
The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.

Claim (Index 5):
The compound of  claim 1 , wherein D is

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14344867', '15398584', '15878291', '15873704', '15878289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7599208993003513
- 35 USC 102 Novelty (BERT): 0.5883872980165683
- Combined Prediction Score: 0.742767539171973
- Mean Citation Score: 395.11885
- Max Citation Score: 471.4058
- Similarity Product: 448.7914255965233

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test